Literature DB >> 11858671

Tyropeptins A and B, new proteasome inhibitors produced by Kitasatospora sp. MK993-dF2. I. Taxonomy, isolation, physico-chemical properties and biological activities.

I Momose1, R Sekizawa, H Hashizume, N Kinoshita, Y Homma, M Hamada, H Iinuma, T Takeuchi.   

Abstract

Tyropeptins A and B, new proteasome inhibitors, were isolated from the culture broth of Kitasatospora sp. MK993-dF2. They were purified using ethyl acetate extraction, silica gel column chromatography, Sephadex LH-20 column chromatography and HPLC. Tyropeptin A inhibited the chymotrypsin-like (ChT-L) and trypsin-like (T-L) activities of 20S proteasome with IC50 values of 0.1 microg/ml and 1.5 microg/ml respectively, but did not inhibit the peptidylglutamyl-peptide hydrolyzing (PGPH) activity of 20S proteasome at a concentration of 100 microg/ml. The inhibitory activities of tyropeptin A were about two times as strong as that of tyropeptin B. Taxonomy of the producing strain is also described.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11858671     DOI: 10.7164/antibiotics.54.997

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  8 in total

1.  In vivo imaging of proteasome inhibition using a proteasome-sensitive fluorescent reporter.

Authors:  Isao Momose; Daisuke Tatsuda; Shun-ichi Ohba; Tohru Masuda; Daishiro Ikeda; Akio Nomoto
Journal:  Cancer Sci       Date:  2012-07-11       Impact factor: 6.716

2.  Combined 3D-QSAR, molecular docking and molecular dynamics study on derivatives of peptide epoxyketone and tyropeptin-boronic acid as inhibitors against the β5 subunit of human 20S proteasome.

Authors:  Jianling Liu; Hong Zhang; Zhengtao Xiao; Fangfang Wang; Xia Wang; Yonghua Wang
Journal:  Int J Mol Sci       Date:  2011-03-09       Impact factor: 5.923

Review 3.  Targeting the ubiquitin pathway for cancer treatment.

Authors:  Jia Liu; Shavali Shaik; Xiangpeng Dai; Qiong Wu; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-12-04

Review 4.  Proteasome regulators: activators and inhibitors.

Authors:  Li Huang; Chin Ho Chen
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

5.  Antitumor effects of tyropeptin-boronic acid derivatives: New proteasome inhibitors.

Authors:  Isao Momose; Hikaru Abe; Takumi Watanabe; Shun-ichi Ohba; Kanami Yamazaki; Shingo Dan; Takao Yamori; Tohru Masuda; Akio Nomoto
Journal:  Cancer Sci       Date:  2014-10-21       Impact factor: 6.716

6.  Natural product scaffolds as inspiration for the design and synthesis of 20S human proteasome inhibitors.

Authors:  Grace E Hubbell; Jetze J Tepe
Journal:  RSC Chem Biol       Date:  2020-09-16

7.  Nostocyclopeptides as New Inhibitors of 20S Proteasome.

Authors:  Anna Fidor; Katarzyna Cekała; Ewa Wieczerzak; Marta Cegłowska; Franciszek Kasprzykowski; Christine Edwards; Hanna Mazur-Marzec
Journal:  Biomolecules       Date:  2021-10-08

8.  Peptide and Peptide-Like Modulators of 20S Proteasome Enzymatic Activity in Cancer Cells.

Authors:  Carlos García-Echeverría
Journal:  Int J Pept Res Ther       Date:  2006-03-04       Impact factor: 1.931

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.